ACTAVIS PHARMACEUTICALS
LIVE

Serial Number

79128751

Owner

Actavis Group PTC ehf

Attorney

GABRIELLE S. ROTH

Filing Date

Nov 21, 2012

Add to watchlist:

No watchlists yet
View on USPTO

ACTAVIS PHARMACEUTICALS Trademark

Serial Number: 79128751 • Registration: 4673382

ACTAVIS PHARMACEUTICALS is a trademark filed by Actavis Group PTC ehf on November 21, 2012. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Actavis Group PTC ehf (50 trademarks)

Dalshraun 1

Entity Type: 78

Trademark Details

Filing Date

November 21, 2012

Registration Date

January 20, 2015

Published for Opposition

September 10, 2013

Cancellation Date

November 22, 2022

Goods & Services

Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development

Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use. pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators

Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth

Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry

Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 12, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 11, 2023 DETH
NEW REPRESENTATIVE AT IB RECEIVED
Oct 22, 2022 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 15, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 20, 2022 INTS
INVALIDATION PROCESSED
Jul 19, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 6, 2022 INTR
CANCELLED SECTION 71
Aug 6, 2021 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 20, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 28, 2015 FICS
FINAL DISPOSITION PROCESSED
May 28, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 20, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2015 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Dec 17, 2014 TMBN
OPPOSITION TERMINATED NO. 999999
Dec 17, 2014 OP.T
OPPOSITION DISMISSED NO. 999999
Dec 17, 2014 OP.D
REFUSAL PROCESSED BY IB
May 29, 2014 RFNP
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
May 8, 2014 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
May 6, 2014 OPNC
OPPOSITION INSTITUTED NO. 999999
Mar 4, 2014 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 3, 2013 ETOF
NOTIFICATION PROCESSED BY IB
Sep 16, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2013 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 28, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 28, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 6, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2013 TROA
DATA MODIFICATION COMPLETED
Jul 22, 2013 DMCC
ASSIGNED TO LIE
Jul 22, 2013 ALIE
ATTORNEY REVIEW COMPLETED
Jul 21, 2013 ATRV
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 16, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2013 REAP
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jul 8, 2013 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 6, 2013 CRCV
REFUSAL PROCESSED BY IB
Jun 8, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 15, 2013 RFCS
REFUSAL PROCESSED BY MPU
May 15, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2013 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
May 7, 2013 MAFR
ASSIGNED TO EXAMINER
May 3, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 3, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2013 REPR